
    
      Patients with non-resectable Non-small Cell Lung Cancer will receive thoracic radiation
      therapy 60-70 Gy over 30-35 fractions and concurrent with Erlotinib 150mg/day. Followed by
      Erlotinib 150 mg/day consolidation treatment.
    
  